Kidney in a box: Advancements in transplant technology allows for quicker recovery

A groundbreaking advancement in transplant medicine has been introduced at the University of Alberta Hospital in Edmonton, marking a pivotal moment in organ transportation and patient recovery. The XVIVO Kidney Assist Transport, approved by Health Canada at the end of 2025, has become the first such system used in Canada. This innovative device, referred to as the "kidney in a box," enables the transport of kidneys from deceased donors to recipients with significantly improved outcomes. Dr. Max Levine, the surgical director of the U of A Hospital's kidney transplant program, explained the benefits of the technology. He noted that the XVIVO introduces oxygen into the circulation during transport, enhancing the viability of the donated organ. This innovation is particularly crucial for kidneys sourced from deceased donors, which traditionally face a higher risk of injury and subsequent failure in recipients. According to Levine, the technology reduces tissue damage and accelerates recovery times for transplant recipients. The implementation of the XVIVO marks a major step forward in transplant procedures, especially given the high demand for kidney transplants in Alberta. Give Life Alberta reports that over 300 individuals are currently awaiting a kidney transplant. Dr. Levine emphasized the importance of adopting cutting-edge technology to improve patient care. "With growing evidence behind it, we wanted to implement this for our patients so we jumped in head first," he stated. One of the first patients to benefit from the new technology is David Cliplef, a veterinarian who has lived with kidney failure for four years. Diagnosed with approximately 15 percent kidney function, Cliplef's condition fluctuated until it stabilized at around seven percent. During this time, he relied on dialysis while awaiting a transplant. When a suitable kidney became available from an older deceased donor, it was transported using the XVIVO system, paired with robotic-assisted surgery. Cliplef described the impact of these technological advances on his recovery. "Because of the technology and the advancements we've had in our program here, we were able to marry those two emerging technologies in transplant and he was able to benefit from those," said Levine. Cliplef's post-operative recovery was notably swift. Within a few days of surgery, he was up and walking, and he was discharged from the hospital after about seven to eight days. His current kidney function has reached 60 percent, which is considered normal, although it has slightly declined. Despite this, Cliplef reports having significantly more energy compared to his time on dialysis. He has resumed work at the veterinary clinic, spending three days a week. "It’s nice to feel better, to have more energy and be more optimistic about things going forward," he remarked. The success of the XVIVO Kidney Assist Transport at the University of Alberta Hospital highlights the potential for similar innovations to transform transplant practices nationwide. As the technology continues to be adopted, it promises to enhance the quality of life for many patients awaiting kidney transplants.